News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Probably not since the current SHOT ticker works very well for the new company name too.
However, anyone can ask questions to company management via the contact page on their website here: https://sureshot.com/pages/contact
$SHOT News: Safety Shot, the world's first clinically proven alcohol reducer, rebrands as Sure Shot and unveils a bold new look, focusing on 4-ounce bottles and powder stick packs
The Rebrand, Led by Amalgam, Is Inspired by Comic Book Like Art to Embody the Product's Powerful and Transformative Functionality
JUPITER, Fla., Oct. 9, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company"), the revolutionary dietary supplement dedicated to stopping the negative effects of alcohol before they start, announced a significant transformation with a complete brand overhaul and a new name: Sure Shot. The rebrand features a fresh new look, as well as a newly improved taste, that underscores the powerful impact of this game-changing product and marks the debut of 4-ounce bottles and on-the-go powder stick packs in the market.
Sure Shot partnered with Amalgam, a full-service agency known for building bespoke teams of marketing experts with a proven track record of growing brands. Amalgam helps both established companies and startups define, refine, and express a distinctive position in their markets. Amalgam led the repositioning and rebranding efforts in partnership with Stout Design.
The new strategy centers on Sure Shot's mission to pioneer the world's most innovative functional beverages, pledging to explore cutting-edge advancements and create a unique market category. As the only clinically proven alcohol reducer, Sure Shot aims to establish itself as the sole occupant of this space, stopping the morning after before it starts.
"We created a bold brand world inspired by pop art and comic strip elements, capturing the dynamism and punch that Sure Shot delivers through its innovative promise," said Ned Wallroth, founder of Amalgam, who also serves as Fractional CMO for the brand.
To coincide with the rebrand, Sure Shot will debut 4-ounce bottles and on-the-go powder stick packs – both portable, compact and convenient forms of its innovative formula – designed for easy on-the-go use, to ensure that customers can enjoy the benefits of Sure Shot's groundbreaking formula wherever they are. The 4-ounce bottles ($5.99) and powder stick packs (coming soon) will be available for purchase in convenience stores and liquor stores across the United States where Sure Shot is sold.
"We could not be more pleased to introduce the new and improved Sure Shot look to the world," said Sure Shot CEO Jarret Boon. "This rebrand marks an exciting new chapter for the Company as we embrace a bold identity that communicates our powerful innovation and revolutionary solution to the masses. Our rebrand isn't just about aesthetic; it represents the evolution of the brand, which has seen exponential growth in its first year, and our commitment to where we see Sure Shot in the future."
The rebrand announcement comes just about a month after the brand released new clinical data that proves the formula's efficacy in rapidly and dramatically reducing BAC and unwanted effects of alcohol. The double-blind, randomized, placebo-controlled study evaluated the acute impact of the Sure Shot formula on consumer's Blood Alcohol Content ("BAC"), successfully demonstrating remarkable and statistically significant results in various measures related to alcohol consumption and the subsequent rapid reduction of BAC by supporting the metabolism of alcohol.
For more information about Sure Shot, please visit http://www.sureshot.com and follow on social @sureshot (alt of @drinksureshot)
About Sure Shot, Inc.
Sure Shot, Inc. a wellness and dietary supplement company dedicated to the promotion of responsible drinking, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Sure Shot is available for purchase online at http://www.sureshot.com and Amazon. The Company is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Sure Shot's ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Sure Shot's future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Sure Shot's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Sure Shot and the risks and uncertainties that are described more fully in the section titled "Risk Factors" in Sure Shot's quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 14, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Sure Shot undertakes no duty to update such information except as required under applicable law.
https://c212.net/c/img/favicon.png?sn=LA26383&sd=2024-10-09 View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-shot-the-worlds-first-clinically-proven-alcohol-reducer-rebrands-as-sure-shot-and-unveils-a-bold-new-look-focusing-on-4-ounce-bottles-and-powder-stick-packs-302270920.html
SOURCE Sure Shot
7-11 does their due diligence. The only scam involved are those shorts trying to save their asses.
This company will be bought out. Probably Ann Heister Bush will buy them to nurse their ongoing
hangover from Dylan Muhlavainie and her/him Bud Light ads. Oh that 4 billion dollar hickey hurt!
SHOT is going to be the shot slugged down around the world. Thanks 7-11 for your Big Gulp of SHOT
support.
$SHOT News: Safety Shot’s Game Changing Blood Alcohol Reduction Beverage to Hit 7-Eleven Stores in Chicago
September 30 2024 - 8:30AM
Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) is excited to announce that 4 oz. bottles of Safety Shot, the world’s first beverage to reduce blood alcohol content, will soon be sold at 7-Eleven convenience stores in the Chicago area.
Working in a partnership with the President and board members of the Francise Owners Association (FOA) Chicago, Safety Shot will launch its convenient on-the-go 4 oz. bottles at 315 7-Eleven stores in the Chicago area.
The product will have a counter-top placement and will be priced at $5.99 each and $10 for two.
In 1927, 7-Eleven showed the world just how convenient shopping could be and has been doing it every day since. 7-Eleven is the world's largest convenience store chain with more than 12,000 locations in the U.S. alone and generated $72 billion in sales last year. The convenience store offers food, snacks, alcohol, and so much more.
Many retailers report their highest alcohol sales in the fourth quarter of the year (from October until New Years Eve). With the large number of holiday gatherings—not to mention the added stress of the season— the fall and winter holidays are one of the most popular times for alcohol use.
“To be distributed in one of the most recognized convenience stores is monumental in driving Safety Shot’s commercialization efforts. The fall and winter seasons see an uptick in alcohol sales making it the best time for Safety Shot to be on the countertops of over 300 7-Eleven stores in a large metropolis city,” stated Safety Shot CEO Jarrett Boon. “The Chicago area is the third largest metropolitan area in the United States and the fourth largest metropolitan area in North America. We will continue to evaluate more strategic launches for Safety Shot’s easy on-the-go bottles.”
For more information on Safety Shot, visit http://www.drinksafetyshot.com and Amazon.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot's ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot's future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled "Risk Factors" in Safety Shot's Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission on August 15, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Media and Investor Contact:
Autumn Communications
Jess Weinberger
Phone: 201-213-3239
Email: shot@autumncommunications.com
Investor Relations
Medon Michaelides
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
$SHOT News: Safety Shot Spins Off Caring Brands Business with Plans to Issue a Dividend to Shareholders
September 26 2024 - 9:15AM
Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) is excited to announce that the Company has entered into a Separation and Exchange Agreement with its subsidiary Caring Brands, Inc. (“Caring Brands”) whereby Caring Brands will operate as its own entity.
Safety Shot is transferring its wellness consumer products segment, along with associated assets, intellectual property, and liabilities, to Caring Brands, an innovative developer of natural based therapeutics and wellness products. Caring Brands focuses on the treatment of hair growth, psoriasis, vitiligo, and atopic dermatitis (eczema).
Spinning off the wellness unit will help each separate entity to pursue its own distinct strategy and business, while allowing shareholders to evaluate how each business is performing.
Moving forward Caring Brands will be responsible for all costs associated with the operation of its wellness business. Caring Brands’ intent is to go public via an initial public offering (IPO) within the next three months.
As part of the agreement to divest Caring Brands, Safety Shot will receive three million shares of Caring Brands stock. To create value for shareholders, the Company’s Board plans to issue a dividend of two million shares for Safety Shot shareholders.
"Separating our wellness business into its own public entity is a strategic move that allows the Company to maximize its efforts on the commercialization of the Safety Shot Dietary Supplement, our proprietary supplement that reduces Blood Alcohol Content by supporting the metabolism of alcohol.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024. For more information on Safety Shot, visit http://www.drinksafetyshot.com and Amazon.
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot’s ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot’s future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled “Risk Factors” in Safety Shot’s Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission on August 15, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Media and Investor Contact:
Autumn Communications
Jess Weinberger
Phone: 201-213-3239
Email: shot@autumncommunications.com
Investor Relations
Medon Michaelides
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
$SHOT News: Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
New Patent is Added to the Company's Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content
JUPITER, Fla., Sept. 6, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or "the Company"), a wellness company behind the world's first rapid alcohol reducer that lowers blood alcohol content ("BAC") by supporting its metabolism in as little as 30 minutes, has announced the Notice of Allowance of for a U.S. patent that covers its newest clinically-backed formula.
"This latest patent marks a significant milestone in Safety Shot's quest to lead a brand-new category that the Company has created to solve alcohol related problems," stated Safety Shot COO and co-owner of the patent, David Sandler.
The Company's family of patents aims to corroborate Safety Shot's competitive advantage in the market which includes being faster at removing alcohol, improving cognitive ability, and reducing impairment by supporting the metabolism of alcohol. The latest patent continues to advance an exciting new category of functionality.
"The patent locks up our IP and further separates us from the pack as the only the group that has been able prove that Safety's Shot revolutionary formula can dramatically reduce blood alcohol and reduce the build-up toxins associated with alcohol consumption rapidly. This patent helps solidify Safety Shot as the uncontested world leader in making people feel better faster," continued Sandler, who co-invented the Safety Shot wellness product.
"The patent allows Safety Shot to exercise authority over specific claims in the marketplace. It further proves our commitment to finding solutions for consumers while taking a hard stance against other companies that enter the category with inferior products. Our patents provide enforceable support to our industry-leading clinical findings," noted Safety Shot CEO and patent co-owner, Jarret Boon.
As part of the Company's efforts to be recognized as the world leader in combating the ill effects of alcohol, the team at Safety Shot is committed to advancing its science through its robust R&D platform that offers a variety of formats using its clinically proven, patented formula.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot's ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot's future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled "Risk Factors" in Safety Shot's Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission on August 15, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-notice-of-allowance-for-new-patent-to-secure-ip-and-enforce-clinically-backed-claims-302240640.html
SOURCE Safety Shot
NEWS: $SHOT Safety Shot Announces Partnership with Digital Growth Platform VENDO
Safety Shot, Inc.
Wed, Aug 28, 2024, 8:00 AM EDT
In this article:
SHOT , SHOTW
-5.00%
Safety Shot, Inc. - As Masters in the E-Commerce Space VENDO is Anticipated to Significantly Help to Grow the Safety Shot Brand Online.
JUPITER, Fla., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”), a wellness company behind the world's first alcohol detoxifier that reduces blood alcohol content by supporting its metabolism in as little as 30 minutes, today announced a partnership with fully-customizable multi-purpose eCommerce platform VENDO.
Identifying themselves as Amazon experts and Walmart marketplace wizards, VENDO is a platform company that works directly with brands to drive strategic and sustainable growth across the digital ecommerce ecosystem. The company works with Amazon, Walmart.com, TikTok Shop, and all Media Buying channels.
“Partnering with a well-recognized platform in the e-commerce space is an exciting endeavor for the company. These guys are considered the best team in the business and will help Safety Shot grow its brand significantly. With how tremendous online shopping is, this is our newest strategic move in getting products into as many hands as possible,” commented Safety Shot President Jordan Schur.
E-commerce is one of the fastest growing industries worldwide, backed up by some seriously impressive numbers. Forbes reported that global e-commerce was worth 6.3 trillion dollars in 2023, which has grown to 6.9 trillion dollars in 2024. 1
From creating beautiful, cohesive content and product display pages, to driving strategy and operations, VENDO ensures your brand’s success is maximized across all Marketplaces online and off. The company’s deep-rooted relationships in retail allow it to help create e-commerce strategy for brands.
“The Best Team in the Biz is fired up to help Safety Shot bring its suite of amazing and innovative products to the masses online for a seamless shopping experience that helps customers purchase wherever they are comfortable checking out so that we can get it in as many hands as possible,” stated VENDO CEO Darren Saul.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot’s ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot’s future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled “Risk Factors” in Safety Shot’s Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission on August 15, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Media and Investor Contact:
Autumn Communications
Jess Weinberger
Phone: 201-213-3239
Email: shot@autumncommunications.com
Investor Relations
Medon Michaelides
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
$SHOT NEWS: Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights
Safety Shot, Inc.
Fri, Aug 16, 2024, 8:30 AM EDT
In this article:
SHOT
+4.32%
SHOTW
+33.33%
Safety Shot, Inc.
- Q2 Revenues Increased 40%
- Q2 Operating Expenses Decreased 17.7%
- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content
- Revolutionary Formula to be Soon Released in Convenient 4-ounce Bottles
- Powdered Version of Alcohol-reducing Nutraceutical to be Released in Q4
JUPITER, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the Company) the revolutionary wellness and dietary supplement company dedicated to the promotion of responsible consumption of alcohol, has released its financial results for its second quarter ended June 30, 2024 as well as a corporate highlights for the quarter.
"We are very excited about our financial performance and our achievements for the second quarter of 2024. A dramatic increase in our revenues with a dramatic decrease in our operating expenses only showcases Safety Shot’s determination to bring value to stakeholders,” stated CEO Jarrett Boon. “We have exciting things expected in the next couple of quarters and believe they will serve as catalysts to further strengthen the company’s financial results going forward. As we continue to execute our business strategy, we remain focused on enhancing our growth potential. This is illustrated by the promising clinical results the company reported this month as well as new partnerships and new product lines the company will be launching in the near future.”
Second Quarter 2024 Highlights:
Company reports a 40% increase in sales in the second quarter compared to the first quarter.
Company reports a 17.7% decrease in operating expenses in the second quarter compared to the first quarter, highlighting significant progress in Safety Shot’s financial health.
Company reveals significant new findings from a recent clinical trial conducted at The Center for Applied Health Sciences ("CAHS"). The double-blind, randomized, placebo-controlled study evaluated the acute impact of Safety Shot on consumer's Blood Alcohol Content ("BAC"), successfully demonstrating remarkable and statistically significant results in various measures related to alcohol consumption and the subsequent rapid reduction of BAC. Within 30 minutes of consuming Safety Shot, participants showed a 30%-50% faster rate of alcohol reduction compared to the placebo group. Safety Shot's proprietary blend of vitamins, minerals and botanical ingredients is now clinically proven as the world's first formula to aid in the rapid reduction of alcohol within the body.
Company is advancing several product formats and formulations to continue to offer a wide array of products that can be purchased at various locations that coincide with consumer shopping habits.
Company announced that its revolutionary formula will be released in new, convenient 4-ounce bottles. Designed for easy on-the-go use, this new format ensures that customers can enjoy the benefits of Safety Shot's groundbreaking formula anytime, anywhere. The 4-ounce bottles are anticipated to launch in Q3.
Company’s R&D team has successfully found a powdered solution that maintains 100% of the efficacy of the world’s first alcohol-reducing product. Safety Shot will offer a convenient stick pack in Q4.
Company announced a partnership with Capital Drugs as the brand expands its nationwide availability. Making strides in connecting the brand to its overarching wellness purpose, Safety Shot will be available in all 300 of the drugstore chain's pharmacies across the United States.
Company announced a strategic partnership with Mr. Checkout, a national network of independent distributors, full-line grocery distributors, and wagon-jobbers. This partnership marks a significant milestone in Safety Shot's mission to provide a revolutionary solution for responsible alcohol consumption to the masses. Additional partnerships include GoPuff, BevMo, and more.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot’s ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot’s future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled “Risk Factors” in Safety Shot’s annual report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on April 1, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Media and Investor Contact:
Autumn Communications
Jess Weinberger
Phone: 201-213-3239
Email: shot@autumncommunications.com
Investor Relations
Medon Michaelides
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
$SHOT Great Article Out! Clinical Trials Validate Safety Shot's Blood Alcohol Reduction and Energy Boost; President Invests Big: (Nasdaq: SHOT)
https://www.einpresswire.com/article/735402309/clinical-trials-validate-safety-shot-s-blood-alcohol-reduction-and-energy-boost-president-invests-big-nasdaq-shot
Great news! "These results are highly encouraging, showcasing Safety Shot's potential as a beneficial supplement for individuals consuming alcohol. The observed reductions in breath and blood alcohol levels, along with the improvements in subjective feelings and physiological measures, highlight the promise of Safety Shot in supporting better outcomes in post-alcohol consumption." $SHOT
For more information about Safety Shot and the full details of the study, please visit http://www.drinksafetyshot.com.
$SHOT News: Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content
First-of-its-kind wellness company Safety Shot announces clinical trials solidifying the brand's dietary supplement's ability to significantly reduce Blood Alcohol Content
JUPITER, Fla., Aug. 12, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company"), the revolutionary wellness and dietary supplement company dedicated to the promotion of responsible consumption of alcohol, announces significant new findings from a recent clinical trial conducted at The Center for Applied Health Sciences ("CAHS"). The double-blind, randomized, placebo-controlled study evaluated the acute impact of Safety Shot on consumer's Blood Alcohol Content ("BAC"), successfully demonstrating remarkable and statistically significant results in various measures related to alcohol consumption and the subsequent rapid reduction of BAC.
The study found that within 30 minutes [of the consumption of Safety Shot], monitored participants reported a highly significant drop in BAC and peak changes in several of the markers responsible for the metabolism of alcohol. Participants between the ages of 24 and 46 with bodyweight ranging between 95 and 225 lbs. showed a dramatic and remarkable difference of 30%-50% faster in the rate at which alcohol was reduced and cleared from the body with the consumption of Safety Shot over the placebo. Participants continued to see measurable drops in successive 30-minute increments, indicating Safety Shot's proprietary blend of vitamins, minerals and botanical ingredients is clinically proven as the world's first formula to aid in the rapid reduction of alcohol within the body.
"This marks a significant change in consumer behavior by providing a safer experience to consume alcohol, as well as better controlled drinking habits to allow for a healthier and more enjoyable environment for the consumer. We are thrilled to finally share the news that after nearly a decade of research and development, our study has successfully confirmed what we have seen in many of our own non-clinical trials," said Chief Operations Officer and co-inventor, David Sandler. "These results are revolutionizing the wellness space as we continue to pioneer the world's most innovative functional beverages," continued Sandler.
Key Findings:
Breath Alcohol Content: Safety Shot proved to consistently lower breath alcohol content at all measured time points compared to the placebo.
Blood Alcohol Content: The study found significant improvements in BAC in the area under the curve (AUC) and maximum concentration (Cmax) for ethanol, acetaldehyde, and aldehyde dehydrogenase levels, favoring Safety Shot.
Physical Results: Trial participants reported significantly less head discomfort, reduced fatigue, increased energy levels, improvements in concentration and reduced feelings of tiredness at multiple time points throughout the study.
These groundbreaking findings indicate Safety Shot's efficacy in supporting user metabolism to reduce BAC and ultimately enhance subjective feelings of well-being and physiological responses post-alcohol consumption. The study's results are currently being compiled into a manuscript, which will be submitted to a biomedical journal for peer review and publication.
Dr. Tim Ziegenfuss, CEO of CAHS stated, "These results are highly encouraging, showcasing Safety Shot's potential as a beneficial supplement for individuals consuming alcohol. The observed reductions in breath and blood alcohol levels, along with the improvements in subjective feelings and physiological measures, highlight the promise of Safety Shot in supporting better outcomes in post-alcohol consumption."
For more information about Safety Shot and the full details of the study, please visit http://www.drinksafetyshot.com.
About Safety Shot, Inc.
Safety Shot, Inc. a wellness and dietary supplement company dedicated to the promotion of responsible drinking, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars throughout 2024.
About CAHS
The Center for Applied Health Sciences is an industry leading CRO (Contract Research Organization) that is committed to providing cost-effective, customized research solutions to suit the needs of natural products, dietary supplements, functional food and beverage industries. www.thecahs.com
Forward-Looking Statements
This press release includes certain disclosures that contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot's ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot's future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled "Risk Factors" in Safety Shot's annual report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on April 1, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
https://c212.net/c/img/favicon.png?sn=LA81625&sd=2024-08-12 View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-powerful-data-analysis-from-recent-clinical-trial-confirming-dramatic-reduction-of-blood-alcohol-content-302219890.html
SOURCE Safety Shot
AI
